Jubilant Pharmova Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Sun Pharma Advanced Research Company Ltd, Five-Star Business Finance Ltd, The Ramco Cements Ltd, Aditya Birla Real Estate Ltd are among the other stocks to see a surge in volumes on BSE today, 16 December 2024.

Jubilant Pharmova Ltd notched up volume of 5.34 lakh shares by 10:46 IST on BSE, a 29 fold spurt over two-week average daily volume of 18403 shares. The stock slipped 2.06% to Rs.1,093.20. Volumes stood at 17130 shares in the last session.

Sun Pharma Advanced Research Company Ltd saw volume of 2.23 lakh shares by 10:46 IST on BSE, a 8.53 fold spurt over two-week average daily volume of 26087 shares. The stock increased 9.15% to Rs.231.45. Volumes stood at 21924 shares in the last session.

Five-Star Business Finance Ltd registered volume of 96529 shares by 10:46 IST on BSE, a 2.68 fold spurt over two-week average daily volume of 36031 shares. The stock rose 3.43% to Rs.671.50. Volumes stood at 38641 shares in the last session.

The Ramco Cements Ltd witnessed volume of 37604 shares by 10:46 IST on BSE, a 2.52 times surge over two-week average daily volume of 14922 shares. The stock increased 0.47% to Rs.1,045.80. Volumes stood at 36870 shares in the last session.

Aditya Birla Real Estate Ltd clocked volume of 8626 shares by 10:46 IST on BSE, a 2.19 times surge over two-week average daily volume of 3939 shares. The stock gained 2.40% to Rs.2,818.25. Volumes stood at 3690 shares in the last session.

Powered by Capital Market - Live News

Net profit of Jubilant Pharmova rose 64.48% to Rs 102.80 crore in the quarter ended September 2024 as against Rs 62.50 crore during the previous quarter ended September 2023. Sales rose 4.53% to Rs 1742.20 crore in the quarter ended September 2024 as against Rs 1666.70 crore during the previous quarter ended September 2023.

Powered by Capital Market - Live News

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 25 October 2024.

Powered by Capital Market - Live News

The United States Food & Drug Administration (USFDA) conducted an audit of the facility from 28 May to 6 June 2024. The US drug regulatorhas now determined the inspection classification of the facility as “Voluntary Action Indicated”.

Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma, Singapore, a wholly owned subsidiary of the company.

Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, CDMO of sterile injectable, generics, contract research development and manufacturing (CRDMO) and proprietary novel drugs businesses.

The company's consolidated net profit stood at Rs 482.10 crore in Q1 FY25, steeply higher than Rs 6.40 crore in Q1 FY24. Total income increased by 9.41% YoY to Rs 1,745.7 crore in Q1 FY25.

The counter hit an all time high of 1,060.15 in today’s intraday session.

Powered by Capital Market - Live News